• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新生功能获得性 KCNT1 通道突变导致婴儿局灶性癫痫伴游走性阵挛。

De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy.

机构信息

Department of Pediatric Neurology, Centre de Reference Epilepsies Rares, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, France.

出版信息

Nat Genet. 2012 Nov;44(11):1255-9. doi: 10.1038/ng.2441. Epub 2012 Oct 21.

DOI:10.1038/ng.2441
PMID:23086397
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3687547/
Abstract

Malignant migrating partial seizures of infancy (MMPSI) is a rare epileptic encephalopathy of infancy that combines pharmacoresistant seizures with developmental delay. We performed exome sequencing in three probands with MMPSI and identified de novo gain-of-function mutations affecting the C-terminal domain of the KCNT1 potassium channel. We sequenced KCNT1 in 9 additional individuals with MMPSI and identified mutations in 4 of them, in total identifying mutations in 6 out of 12 unrelated affected individuals. Functional studies showed that the mutations led to constitutive activation of the channel, mimicking the effects of phosphorylation of the C-terminal domain by protein kinase C. In addition to regulating ion flux, KCNT1 has a non-conducting function, as its C terminus interacts with cytoplasmic proteins involved in developmental signaling pathways. These results provide a focus for future diagnostic approaches and research for this devastating condition.

摘要

婴儿恶性游走部分性癫痫发作(MMPSI)是一种罕见的婴儿癫痫性脑病,其特征是对抗癫痫药物耐药性的癫痫发作和发育迟缓。我们对 3 名 MMPSI 先证者进行了外显子组测序,发现了影响 KCNT1 钾通道 C 末端结构域的新生获得性功能突变。我们对 9 名 MMPSI 患儿进行了 KCNT1 测序,其中 4 名患儿发现了突变,总共在 12 名无血缘关系的患儿中发现了 6 名患儿有突变。功能研究表明,这些突变导致通道的组成型激活,模拟了蛋白激酶 C 对 C 末端结构域磷酸化的作用。除了调节离子流外,KCNT1 还具有非传导功能,因为其 C 末端与参与发育信号通路的细胞质蛋白相互作用。这些结果为这种破坏性疾病的未来诊断方法和研究提供了重点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39e9/3687547/ac65207fa1ca/nihms476852f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39e9/3687547/faf806b88be4/nihms476852f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39e9/3687547/4150831981c3/nihms476852f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39e9/3687547/ac65207fa1ca/nihms476852f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39e9/3687547/faf806b88be4/nihms476852f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39e9/3687547/4150831981c3/nihms476852f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39e9/3687547/ac65207fa1ca/nihms476852f3.jpg

相似文献

1
De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy.新生功能获得性 KCNT1 通道突变导致婴儿局灶性癫痫伴游走性阵挛。
Nat Genet. 2012 Nov;44(11):1255-9. doi: 10.1038/ng.2441. Epub 2012 Oct 21.
2
Characterization of two de novoKCNT1 mutations in children with malignant migrating partial seizures in infancy.婴儿期恶性游走性局灶性癫痫患儿中两个新发KCNT1突变的特征分析
Mol Cell Neurosci. 2016 Apr;72:54-63. doi: 10.1016/j.mcn.2016.01.004. Epub 2016 Jan 16.
3
A recurrent KCNT1 mutation in two sporadic cases with malignant migrating partial seizures in infancy.两个散发病例中存在 KCNT1 基因突变,表现为婴儿期恶性游走性部分性癫痫发作。
Gene. 2013 Dec 1;531(2):467-71. doi: 10.1016/j.gene.2013.08.096. Epub 2013 Sep 10.
4
Clinical and molecular characterization of -related severe early-onset epilepsy.- 相关严重早发性癫痫的临床和分子特征。
Neurology. 2018 Jan 2;90(1):e55-e66. doi: 10.1212/WNL.0000000000004762. Epub 2017 Dec 1.
5
A challenging case of epilepsy in infancy with migrating focal seizures due to a de novo KCNT1 missense variant (c.1438G>A, p.Asp480Asn).一例因新发KCNT1错义变异(c.1438G>A,p.Asp480Asn)导致婴儿期癫痫伴游走性局灶性发作的疑难病例。
Seizure. 2024 Apr;117:202-205. doi: 10.1016/j.seizure.2024.02.020. Epub 2024 Feb 29.
6
Quantitative analysis and EEG markers of KCNT1 epilepsy of infancy with migrating focal seizures.婴儿移行性局灶性癫痫伴 KCNT1 发作的定量分析和 EEG 标志物。
Epilepsia. 2019 Jan;60(1):20-32. doi: 10.1111/epi.14605. Epub 2018 Dec 7.
7
Three Cases of KCNT1 Mutations: Malignant Migrating Partial Seizures in Infancy with Massive Systemic to Pulmonary Collateral Arteries.三例KCNT1突变:婴儿期恶性游走性部分性癫痫伴大量体循环至肺循环侧支动脉
J Pediatr. 2017 Dec;191:270-274. doi: 10.1016/j.jpeds.2017.08.057. Epub 2017 Oct 5.
8
A quinidine non responsive novel KCNT1 mutation in an Indian infant with epilepsy of infancy with migrating focal seizures.一名患有婴儿期迁移性局灶性癫痫发作的印度婴儿中一种对奎尼丁无反应的新型KCNT1突变。
Brain Dev. 2018 Mar;40(3):229-232. doi: 10.1016/j.braindev.2017.09.008. Epub 2017 Oct 14.
9
KCNT1 epilepsy with migrating focal seizures shows a temporal sequence with poor outcome, high mortality and SUDEP.KCNT1 癫痫伴游走性局灶性发作具有不良预后、高死亡率和 SUDEP 的时间序列。
Brain. 2019 Oct 1;142(10):2996-3008. doi: 10.1093/brain/awz240.
10
Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy.两名婴儿癫痫伴局灶性阵挛发作(EIMFS)因 KCNT1 功能获得性突变所致,早期应用奎尼丁治疗:功能研究、临床反应及个体化治疗的关键问题。
Neurotherapeutics. 2018 Oct;15(4):1112-1126. doi: 10.1007/s13311-018-0657-9.

引用本文的文献

1
Role of hippocampus in epileptogenesis: new insights in the cross-talks between the underlying mechanisms.海马体在癫痫发生中的作用:潜在机制间相互作用的新见解
Acta Neurol Belg. 2025 Aug 9. doi: 10.1007/s13760-025-02857-1.
2
KCNT1 gene variant-associated epilepsy: genetic insights, functional mechanisms, and emerging therapies.KCNT1基因变异相关癫痫:遗传学见解、功能机制及新兴疗法
J Neurol. 2025 Jun 21;272(7):472. doi: 10.1007/s00415-025-13207-9.
3
Developmental mechanisms underlying pediatric epilepsy.小儿癫痫的发育机制。

本文引用的文献

1
KCNQ2 encephalopathy: emerging phenotype of a neonatal epileptic encephalopathy.KCNQ2 脑病:一种新生儿癫痫性脑病的新表型。
Ann Neurol. 2012 Jan;71(1):15-25. doi: 10.1002/ana.22644.
2
A case of malignant migrating partial seizures in infancy as a continuum of infantile epileptic encephalopathy.一例婴儿期恶性迁移性部分性癫痫,为婴儿癫痫性脑病的一种连续表现。
Brain Dev. 2012 Oct;34(9):768-72. doi: 10.1016/j.braindev.2011.11.011. Epub 2011 Dec 24.
3
De novo SCN1A mutations in migrating partial seizures of infancy.婴儿移行性部分性发作中的从头 SCN1A 突变。
Front Neurol. 2025 Jun 3;16:1586947. doi: 10.3389/fneur.2025.1586947. eCollection 2025.
4
Mapping the knowledge of epilepsy and Potassium Channels: A scientometric analysis in CiteSpace and VOSviewer.绘制癫痫与钾通道的知识图谱:CiteSpace和VOSviewer中的科学计量分析
IBRO Neurosci Rep. 2025 May 31;19:1-16. doi: 10.1016/j.ibneur.2025.05.004. eCollection 2025 Dec.
5
Neuronal potassium channel activity triggers initiation of mRNA translation through binding of translation regulators.神经元钾通道活性通过翻译调节因子的结合触发mRNA翻译的起始。
Sci Adv. 2025 May 30;11(22):eadv3140. doi: 10.1126/sciadv.adv3140. Epub 2025 May 28.
6
International Precision Child Health Partnership (IPCHiP): an initiative to accelerate discovery and improve outcomes in rare pediatric disease.国际精准儿童健康伙伴关系(IPCHiP):一项加速罕见儿科疾病发现并改善治疗结果的倡议。
NPJ Genom Med. 2025 Feb 27;10(1):13. doi: 10.1038/s41525-025-00474-8.
7
Fluoxetine Treatment in Epilepsy of Infancy with Migrating Focal Seizures Due to KCNT1 Variants: An Open Label Study.氟西汀治疗因KCNT1变异导致的婴儿期迁移性局灶性癫痫:一项开放标签研究。
Ann Neurol. 2025 Feb 21. doi: 10.1002/ana.27213.
8
Fasudil inhibits α-synuclein aggregation through ROCK-inhibition-mediated mechanisms.法舒地尔通过ROCK抑制介导的机制抑制α-突触核蛋白聚集。
Neurotherapeutics. 2025 Mar;22(2):e00544. doi: 10.1016/j.neurot.2025.e00544. Epub 2025 Feb 5.
9
Small molecule inhibits KCNQ channels with a non-blocking mechanism.小分子通过非阻断机制抑制钾电压门控通道亚家族KQT成员通道。
Nat Chem Biol. 2025 Jan 15. doi: 10.1038/s41589-024-01834-8.
10
Structure-Activity Relationship Studies in a Series of 2-Aryloxy--(pyrimidin-5-yl)acetamide Inhibitors of SLACK Potassium Channels.一系列2-芳氧基--(嘧啶-5-基)乙酰胺类SLACK钾通道抑制剂的构效关系研究
Molecules. 2024 Nov 21;29(23):5494. doi: 10.3390/molecules29235494.
Neurology. 2011 Jul 26;77(4):380-3. doi: 10.1212/WNL.0b013e318227046d. Epub 2011 Jul 13.
4
Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations.外显子组测序在散发性自闭症谱系障碍中发现严重的新生突变。
Nat Genet. 2011 Jun;43(6):585-9. doi: 10.1038/ng.835. Epub 2011 May 15.
5
Malignant migrating partial seizures in a 4-month-old boy.4 个月男婴的恶性游走性部分性发作。
Epileptic Disord. 2011 Jun;13(2):185-7. doi: 10.1684/epd.2011.0424.
6
Novel SCN1A mutation in a proband with malignant migrating partial seizures of infancy.一名患有婴儿期恶性游走性局灶性癫痫的先证者中的新型SCN1A突变。
Arch Neurol. 2011 May;68(5):665-71. doi: 10.1001/archneurol.2011.98.
7
Treatment of malignant migrating partial epilepsy of infancy with rufinamide: report of five cases.采用鲁非酰胺治疗婴儿恶性游走性部分性癫痫:5 例报告。
Epileptic Disord. 2011 Mar;13(1):18-21. doi: 10.1684/epd.2011.0406.
8
The efficacy of bromides, stiripentol and levetiracetam in two patients with malignant migrating partial seizures in infancy.溴化物、司替戊醇和左乙拉西坦对两名婴儿恶性游走性部分性癫痫发作患者的疗效。
Epileptic Disord. 2011 Mar;13(1):22-6. doi: 10.1684/epd.2011.0402.
9
Intellectual disability without epilepsy associated with STXBP1 disruption.与 STXBP1 缺失相关的不伴癫痫的智力障碍。
Eur J Hum Genet. 2011 May;19(5):607-9. doi: 10.1038/ejhg.2010.183. Epub 2011 Mar 2.
10
Epilepsy genetics--past, present, and future.癫痫遗传学——过去、现在和未来。
Curr Opin Genet Dev. 2011 Jun;21(3):325-32. doi: 10.1016/j.gde.2011.01.005. Epub 2011 Jan 27.